P11. Efficacy and safety of erlotinib in advanced squamous cell lung cancer

BACKGROUND: Erlotinib is epidermal growth factor receptor (EGFR) tyrosine-kinase inhibitor which showed efficacy and tolerability in patients with advanced non-small cell lung cancer (NSCLC), especially in group of patients which harbor activating mutations in EGFR. AIM: To determine safety and effi...

全面介紹

Na minha lista:
書目詳細資料
發表在:Transl Lung Cancer Res
Main Authors: Jakopovic, Marko, Cucevic, Branka, Plestina, Sanja, Kukulj, Suzana, Roglic, Mihovil, Smojver-Jezek, Silvana, Korsic, Marta, Redzepi, Gzim, Samarzija, Miroslav
格式: Artigo
語言:Inglês
出版: Pioneer Bioscience Publishing Company 2014
主題:
CELCC 2014 Abstracts
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367745/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.AB023
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍